BBRI News

Powerful New Cooperative Research Model Possible at Independent Research Institutes

WATERTOWN, Mass. –April 11, 2008 –“Drug makers turning to nonprofits for cash,” [April 7, 2008, Section C] detailed the partnership between biotech/pharmaceutical companies and private foundations to search for cures.  Missing was the role that patients have in bringing these vital partnerships into being with advocacy and start-up funds.  Patient involvement in the therapeutic development pipeline is equally important as basic, translational, and clinical research efforts.
full release
Wallack, Todd. “Drug Makers Turning to Nonprofits for Cash.” Boston Globe 4/07/08.